Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2
- 2 June 2020
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 172 (11), 726-734
- https://doi.org/10.7326/m20-1301
Abstract
Diagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laboratory on respiratory specimens are the reference standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging. Although excellent tools exist for the diagnosis of symptomatic patients in well-equipped laboratories, important gaps remain in screening asymptomatic persons in the incubation phase, as well as in the accurate determination of live viral shedding during convalescence to inform decisions to end isolation. Many affluent countries have encountered challenges in test delivery and specimen collection that have inhibited rapid increases in testing capacity. These challenges may be even greater in low-resource settings. Urgent clinical and public health needs currently drive an unprecedented global effort to increase testing capacity for SARS–CoV-2 infection. Here, the authors review the current array of tests for SARS–CoV-2, highlight gaps in current diagnostic capacity, and propose potential solutions.This publication has 55 references indexed in Scilit:
- Rapid and simple molecular tests for the detection of respiratory syncytial virus: a reviewExpert Review of Molecular Diagnostics, 2018
- Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain ReactionAnnals of Internal Medicine, 2017
- Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysisJournal of Clinical Microbiology, 2015
- A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirusEmerging Microbes & Infections, 2015
- Diagnostic Accuracy of Loopamp Trypanosoma brucei Detection Kit for Diagnosis of Human African Trypanosomiasis in Clinical SamplesPLoS Neglected Tropical Diseases, 2013
- Rapid antigen-based testing for respiratory syncytial virus: moving diagnostics from bench to bedside?Future Microbiology, 2013
- An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-Reactivity with SARS CoronavirusCanadian Journal of Infectious Diseases and Medical Microbiology, 2006
- Late Recognition of SARS in Nosocomial Outbreak, TorontoEmerging Infectious Diseases, 2005
- Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in SARS Patients by Enzyme-Linked Immunosorbent AssayJournal of Clinical Microbiology, 2004
- Critical Role of Nosocomial Transmission in the Toronto SARS OutbreakMathematical Biosciences and Engineering, 2004